on 16 Nov 2021
Last Applicant/ Owned by
Yeonsu-gu Incheon, Korea (Songdo-dong)
KR
Serial Number
79302421 filed on 16th Dec 2020
Registration Number
6557534 registered on 16th Nov 2021
Correspondent Address
Erica R. Halstead
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The mark consists of the stylized wording "DMBiO Y" with the letter "D" in blue, "M" in red, and "BiO" in grey. The letter "Y" appears as a superscript with the left branch in blue, right branch in red, and the stem in grey. Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central Read More
Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in the treatment of gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, and in acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, and in allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer
Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceuticals
No 79302421
No Service Mark
No 403191
No
No
No
No
No
No
No
No
The mark consists of the stylized wording "DMBiO Y" with the letter "D" in blue, "M" in red, and "BiO" in grey. The letter "Y" appears as a superscript with the left branch in blue, right branch in red, and the stem in grey.
Status Date | Action Taken |
---|---|
16th Feb 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
16th Nov 2021 | REGISTERED-PRINCIPAL REGISTER |
31st Aug 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
31st Aug 2021 | PUBLISHED FOR OPPOSITION |
29th Aug 2021 | NOTIFICATION PROCESSED BY IB |
11th Aug 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
11th Aug 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
11th Aug 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
28th Jul 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
11th Jul 2021 | REFUSAL PROCESSED BY IB |